MetaCap

Minerva Neurosciences Statistics

NASDAQ: NERVHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.00-0.12 (-5.66%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Minerva Neurosciences by the numbers

Minerva Neurosciences has a market capitalization of $99.7 million based on 49.84M shares outstanding. With trailing EPS of $-33.83, Minerva Neurosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.6% below its 50-day average and 57.9% below its 200-day average.

Average daily trading volume is 164.71K shares, or about $329,424 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NERV valuation vs. peer median

NERV compared with the median of 8 peer companies
MetricNERVPeer medianDifference
Market cap$99.67M$98.28M+1%
Avg. volume164.71K846.99K-81%

Peer median across 8 companies: ORGO, CNTN, UNCY, NBP, FHTX, GNLX, PDSB, NRXP.

Valuation

Price and trading

Previous close
2.12
Open
2.09
Day range
1.99 – 2.12
52-week range
1.96 – 8.80
52-week change
-49.24%
Beta
—
Volume
137.66K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
99.67M
Forward Pe
-4.76
Eps
-33.83
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
8.80
Week52 Low
1.96
Avg Volume
164.71K
Shares Outstanding
49.84M
Ma50
2.80
Ma200
4.75
Earnings Date
Aug 5, 2025
Pct From52w High
-77.27%
Pct From52w Low
2.04%

Related